A systematic review and retrospective analysis of 1557 patients with advanced or metastatic solid cancers shows that high ALDH1 expression is distinctly associated with poorer overall survival (OS), especially in breast cancer, HNSCC, cervical cancer (CC), and ovarian cancers.21 Here, ALDH1A1 is linked to breast carcinoma.